Equity · Healthcare
CRVS
NASDAQCorvus Pharmaceuticals (CRVS)
The line runs 13 USD on 14 September through 11.36 USD on 9 November, on a scale from 8 to 14. Days the market did not trade hold the previous close, flat.
- Market cap
- 957.8M USD
- EPS, diluted, year to Dec 2025
- −0.53 USD
- 52-week range
- 6.50 USD – 25.08 USD
- Avg volume
- 74.7K
- Mentions, 30 days
- 1
as of Nov 9, 2026
Have Corvus Pharmaceuticals (CRVS) insiders bought or sold shares recently?
CRVS's newest Form 4 filing is dated 11 June 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 11 Jun 2026 | Moore David ScottDirector | Buy | 21,700 | 250K USD |
| 18 May 2026 | MILLER RICHARD A MDPresident and CEO | Buy | 6,932 | 83K USD |
| Bought | 2 open-market purchases | 28,632 | $334K |
5 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 28 Jan 2026 | Thompson Peter A.Director | Option exercise | 210,000 | 1.1M USD |
| 04 Dec 2025 | MILLER RICHARD A MDPresident and CEO | Award | 1,000,000 | |
| 04 Dec 2025 | LEA LEIVChief Financial Officer | Award | 400,000 | |
| 04 Dec 2025 | Arcara JeffreyChief Business Officer | Award | 100,000 | |
| 04 Dec 2025 | Jones William BentonSee Remarks | Award | 400,000 |
Which funds hold Corvus Pharmaceuticals (CRVS)?
1 of the 45 institutional funds we track reported a Corvus Pharmaceuticals position for the quarter ended 30 Sep 2026 — a combined 12.0M USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | New position | 1,040,606 | 12.0M USD |
What has been filed or recorded for Corvus Pharmaceuticals (CRVS)?
The filings we hold for Corvus Pharmaceuticals, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.22 USD | |
| 30 Sep 2026 | Financials | Total assets | 223.9M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 208.3M USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 1,640 shares | 19K USD notional · 0.002% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.19 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.15 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.53 USD | |
| 31 Dec 2025 | Financials | Net income | −15.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.53 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.12 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.10 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.13 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.02 USD |
What is Reddit saying about Corvus Pharmaceuticals (CRVS)?
Reddit mentioned CRVS 1 times in the 30 days to 10 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 0% read bullish, 100% bearish and 0% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Corvus Pharmaceuticals (CRVS) compare with its price?
Share ↗
Which subreddits are talking about Corvus Pharmaceuticals (CRVS)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 1 | −0.17 |
What do people ask about Corvus Pharmaceuticals (CRVS)?
What did Corvus Pharmaceuticals shares close at?11.36
Corvus Pharmaceuticals closed at 11.36 USD on 9 Nov 2026, up 7.58% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Corvus Pharmaceuticals’ market cap?957.8M
Corvus Pharmaceuticals is worth 957.8M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
Have Corvus Pharmaceuticals insiders bought or sold shares recently?
No Corvus Pharmaceuticals insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 11 Jun 2026 (SEC Form 4). See Insiders
Which funds own Corvus Pharmaceuticals?1 of 45
1 of the 45 funds we track reported a Corvus Pharmaceuticals position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
When did Corvus Pharmaceuticals last report earnings?−0.22
Corvus Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.22 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Corvus Pharmaceuticals?0 mentions
Corvus Pharmaceuticals was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 0% read bullish and 100% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings